# OnCo record foundationfocus-cdxbrca (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/foundationfocus-cdxbrca/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "foundationfocus-cdxbrca" ;
  schema:name "FoundationFocus CDxBRCA"@en ;
  schema:alternateName "FoundationFocus CDxBRCA Assay"@en, "FoundationFocus CDxBRCA" ;
  schema:description "Foundation Medicine's first FDA-approved test, a BRCA test for rucaparib in ovarian cancer, since withdrawn in the FDA database."@en ;
  schema:url <https://onco.cc/drugs/foundationfocus-cdxbrca/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160018>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "withdrawn" ;
  onco:tag "test" ;
  onco:modality "Tissue NGS companion diagnostic test (BRCA1 and BRCA2)" ;
  onco:approval "US 2016: Companion diagnostic for rucaparib in ovarian cancer (BRCA1 and BRCA2 alterations)" ;
  onco:related <https://onco.cc/drugs/foundationone-cdx/>, <https://onco.cc/biomarkers/brca-somatic/> ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/rucaparib/> ;
  onco:companies <https://onco.cc/companies/foundation-medicine/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/companion-diagnostic-term/> .